期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

受体型酪氨酸激酶RON在乳腺癌侵袭及转移中的作用研究进展 被引量：1

Development in the role of receptor tyrosine kinase RON in invasion and metastasis of human breast cancer
下载PDF
导出
摘要 受体型酪氨酸激酶RON是原癌基因c-MET家族的一员。本文在简介原癌基因RON的生物学特征的基础上,综述了RON在乳腺癌侵袭及转移中的作用的研究进展,包括RON在乳腺癌中的异常表达、RON变异体、RON促进细胞迁移、肿瘤细胞附着、肿瘤生长和血管生成作用以及其在溶骨性骨转移中的作用等。单克隆抗体、小分子抑制物和特异性siRNA等靶向RON的治疗方法在乳腺癌治疗中有一定的潜在价值。 The receptor tyrosine kinase RON belongs to the c - MET proto - oneogene family. In this review the biological characteristics of RON were briefly introduced. In recent years, more and more research results indicate that RON may take an important role in invasion and metastasis of human breast cancer by aberrant expression in breast cancer, RON variants, promoting tumor cell migration, cell adhesion, invasive growth, angiogenesis as well as proteolytic bone metastasis. Targeted therapeutics using specific monoclonal antibodies, small - molecule inhibitors or siRNA have potential value in the treatment of breast cancer.
作者 莫光泉 张宏颖 李连宏
机构地区 大连医科大学病理学与法医学教研室
出处 《大连医科大学学报》 CAS 2011年第4期391-396,共6页 Journal of Dalian Medical University
基金 教育部博士点基金资助项目(200801610001)
关键词 乳腺肿瘤 受体型酪氨酸激酶RON 侵袭 转移 靶向治疗 breast neoplasms receptor tyrosine kinase RON neoplasm invasiveness matastasis targeted therapy
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献30

  • 1Jemal A,Siegel R,Xu J,et al. Cancer Statistics, 2010 [J]. CA Cancer J Clin, 2010,60 (5) :277 - 300.
  • 2Wagh PK, Peace BE, Waltz SE. Met - related receptor tyrosine kinase Ron in tumor growth and metastasis [J]. Adv Cancer Res,2008,100 : 1 - 33.
  • 3Kretschmann KL,Eyob H, Buys SS, et al. The macrophage stimulating protein/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression [ J ]. Curr Drug Targets, 2010,11 ( 9 ) : 1157 - 1168.
  • 4Suzuki Y, Funakoshi H, Machide M, et al. Regulation of cell migration and cytokine production by HGF -like protein (HLP) / macrophage stimulating protein (MSP) in primary microglia [ J ]. Biomed Res ,2008 ,29 (2) :77 - 84.
  • 5Wang MH, Lee W, Luo YL, et al. Altered expression of the RON receptor tyrosine kinase in various epithelial cancers and its contribution to tumourigenic phenotypes in thyroid cancer cells [ J ]. J Pathol, 2007,213 (4) :402 - 411.
  • 6Thangasamy A, Rogge J, Ammanamanchi S. Regulation of RON tyrosine kinase - mediated invasion of breast cancer cells[J]. J Biol Chem,2008,283 (9) :5335 - 5343.
  • 7Feres K J, Ischenko I, Hayman MJ. The RON receptor tyrosine kinase promotes MSP- independent cell spreading and survival in breast epithelial cells [ J ]. Oncogene, 2009,28 (2) :279 -288.
  • 8Bhatt AS, Welm AL, Farady C J, et al. Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway [ J ]. Proc Natl Acad Sci USA, 2007, 104(14) :5771 - 5776.
  • 9Feres KJ, Hayman MJ. RON - expressing MCF - 10A breast epithelial cells exhibit alterations of hyaluronan expression, promoting RON - mediated early adhesion events [ J ]. Biochem Biophys Res Commun,2010,391 (4) : 1604 - 1609.
  • 10Leonis MA, Thobe MN, Waltz SE. Ron - receptor tyrosine kinase in tumorigenesis and metastasis [ J ]. Future Oncol, 2007,3(4) :441 -448.

二级参考文献74

  • 1Ciardiello F, Tortora C. EGFR antagonists in cancer treatment. N Engl J Med 2008; 358: 1160-74.
  • 2Zwick E, Bange J, UIIrich A. Receptor tyrosine kinase signaling as a target for cancer intervention strategies. Endocr Relat Cancer 2001; 8: 161- 73.
  • 3Dussault I, Bellon SF. From concept to reality: the long road to c-Met and RON receptor tyrosine kinase inhibitors for the treatment of cancer. Anticancer Agents Med Chem 2009; 9: 221-25.
  • 4Liu X, Newton RC, Scherle PA. Developing c-MET pathway inhibitors for cancer therapy: progress and challenges. Trends Mol Med 2010; 16: 37-45.
  • 5Hubbard SR, Miller WT. Receptor tyrosine kinases: mechanisms of activation and signaling. Curr Opin Cell Bio12007; 19: 117-23.
  • 6Xu AM, Huang PH. Receptor tyrosine kinase coactivation networks in cancer. Cancer Res 2010; 70: 3857-60.
  • 7Robertson SC, Tynan JA, Donoghue DJ. RTK mutations and human syndromes when good receptors turn bad. Trends Genet 2000; 16: 265 - 71.
  • 8Porter AC, Vaillancourt RR. Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. Oncogene 1998; 17: 1343-52.
  • 9Blume-Jensen P, Hunter T. Oncogenic kinase signaling. Nature 2001; 411: 355-65.
  • 10Weinstein IB, Joe AK. Mechanisms of disease: Oncogene addiction-a rationale for molecular targeting in cancer therapy. Nat Clin Pract Onco12006; 3: 448-57.

共引文献9

同被引文献7

引证文献1

大连医科大学学报
2011年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部